Trial Profile

A Phase 2 Trial to Evaluate PPP003 in Patients with Moderate to Severe COVID-19 Infection

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 21 Jul 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Onternabez (Primary)
Indications COVID 2019 infections
Focus Therapeutic Use
Sponsors Tetra Bio Pharma

Most Recent Events

16 Jul 2020 According to a Tetra Bio-Pharma media release, the company is planning to initiate this study in parallel to conducting the phase 1 trial in healthy volunteers(Phase 1 is expected to start in late September 2020).
16 Jul 2020 According to a Tetra Bio-Pharma media release, the FDA stated that no additional nonclinical safety studies would be required to initiate phase 2 studies in SARS-COV-2 patients. The FDA also provided detailed feedback on the proposed Phase 1 and 2 clinical trial protocols.
12 May 2020 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com